Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentoxifylline in amphotericin B toxicity rat model.

K M Wasan1, K Vadiei, G Lopez-Berestein

  • 1Department of Pharmaceutics, University of Houston, Texas.

Antimicrobial Agents and Chemotherapy
|February 1, 1990
PubMed
Summary

Pentoxifylline (PTX) mitigates amphotericin B (AmpB)-induced nephrotoxicity in rats by reducing vascular congestion. This hemorheologic agent preserves renal function and prevents significant declines in inulin clearance when coadministered with AmpB.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Oncogene·2020
Same author

<i>In vivo</i> study and thermodynamic investigation of two lanthanum complexes, La(dpp)<sub>3</sub> and La(XT), for the treatment of bone resorption disorders.

Chemical science·2018
Same author

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).

Oncogene·2017
Same author

La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)<sub>3</sub> and La(XT), and evaluation as treatments for bone resorption disorders.

Metallomics : integrated biometal science·2017
Same author

Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.

Oncogene·2016
Same author

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

Oncogene·2016

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Amphotericin B (AmpB) is a critical antifungal agent, but its use is limited by significant nephrotoxicity.
  • The precise mechanisms underlying AmpB-induced kidney damage, including hemodynamic alterations, remain incompletely understood.
  • Pentoxifylline (PTX), a hemorheologic agent, has shown potential in modulating inflammatory and vascular responses.

Purpose of the Study:

  • To investigate the protective effects of pentoxifylline (PTX) against acute amphotericin B (AmpB)-induced nephrotoxicity in a rat model.
  • To elucidate the potential role of PTX in mitigating AmpB-related vascular congestion and preserving renal function.

Main Methods:

  • Acute and chronic studies were conducted in rats using intravenous AmpB with or without intraperitoneal PTX.

Related Experiment Videos

  • Renal function was assessed by inulin clearance (CLIN) and electrolyte handling.
  • Renal morphology, specifically vascular congestion in the medulla and glomeruli, was evaluated histologically.

    • Main Results:

    • AmpB administration significantly decreased inulin clearance (CLIN), an effect attenuated by coadministration of PTX.
    • Histological analysis revealed marked vascular congestion in rats treated with AmpB alone, which was significantly reduced by PTX.
    • In chronic studies, PTX coadministration prevented the substantial decline in CLIN observed in rats treated with AmpB and saline.

    Conclusions:

    • Pentoxifylline (PTX) demonstrates a protective effect against acute amphotericin B (AmpB)-induced nephrotoxicity.
    • The renoprotective benefit of PTX appears to be mediated, at least in part, by its ability to reduce vascular congestion in the kidney.
    • These findings suggest PTX as a potential adjunct therapy to mitigate AmpB-related renal damage.